84 Views | 41 Downloads
Correspondence: E. Jennifer Edelman, MD, Yale School of Medicine, 367 Cedar Street, ESH A, New Haven, CT 06510, phone 203.737.7115 fax 203.737.3306, ejennifer.edelman@yale.edu
Author contributions: EJE helped design the study and obtain grant funding. She oversaw all aspects of the study, interpreted findings, and led the writing and editing of this manuscript. She had full access to study data and takes full responsibility for the decision to submit this manuscript for publication. SAM, NHB, CJC, LEF, and PGO were responsible for the development and implementation of intervention procedures.
JPT contributed to study design, implementation, data conceptualization, and management. YD and JD conducted all analyses. RB, CLG, VCM, DR, MRB, MSS were responsible for overseeing implementation of study procedures at each of their sites. ACJ and KB contributed to the design of the study and provided oversight to study implementation.
DAF designed the study, obtained the grant funding to conduct this study, oversaw conduct of the study, interpreted the data and contributed to the editing of the manuscript.
All authors contributed to interpretation of the findings and editing of the manuscript. We would like to acknowledge Ms. Laura Simone for her efforts in development and design of data tracking system, Ms. Melissa Skanderson for their efforts in data management and Ms. Elizabeth Porter for her efforts in coordinating and implementing this research.
The authors would like to thank the patients and providers who participated in this research.
Disclosures: The authors have no conflicts of interest.
This work was generously support by grants from the National Institute on Alcohol Abuse and Alcoholism (grant #U01AA020795, U01AA020790, U24AA020794).
EJ Edelman was supported as a Yale-Drug Abuse, HIV and Addiction Research Scholar (NIDA grant #K12DA033312) during the conduct of this work.
© 2019 Elsevier Ltd. All rights reserved.